53018-8
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum
Active
Part Description
LP69893-3 Sjogrens syndrome-A extractable nuclear 60kD Ab
Antibodies against the 60-kD Ro (or SS-A) are commonly found in patients with systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS).
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Sjogrens syndrome-A extractable nuclear 60kD Ab:
PrThr: Pt: Ser: Ord: - Long Common Name
- Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum
- Short Name
- ENA SS-a 60kD Ab Ser Ql
- Display Name
- Sjogrens syndrome-A extractable nuclear 60kD Ab Ql (S)
- Consumer Name Alpha Get Info
- Sjogrens syndrome-A extractable nuclear 60kD antibody, Blood
Part Model Get Info
- Component
- Sjogrens syndrome-A extractable nuclear 60kD Ab
LP69893-3
- Analyte
- Sjogrens syndrome-A extractable nuclear 60kD Ab
LP69893-3
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser
LP7567-3
- System Core
- Ser
LP7567-3
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- NULL
Example Answer List: LL360-9
Source: Regenstrief Institute| Answer | Code | Score | Answer ID |
|---|---|---|---|
| PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
| NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 |
Basic Attributes
- Class
- SERO
- Type
- Laboratory
- First Released
- Version 2.24
- Last Updated
- Version 2.56 (MIN)
- Change Reason
- The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG21389-8 | Sjogrens syndrome-A extractable nuclear 60kD Ab| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Antinukleární protilátky Sjögrenův syndrom A extrahovatelné 60kD: |
| de-AT | German (Austria) | Synonyms: SS-A/Ro-60-AK ql. |
| de-DE | German (Germany) | Sjögren-Syndrom-A extrahierbarer nukleärer 60kD Ak: |
| el-GR | Greek (Greece) | Σύνδρομο Sjogrens-Α εκχυλίσιμο πυρηνικό 60kD Αντίσωμα: Synonyms: A Ord PrThr Pt SERO Αντίσωμα Εκχυλίσιμα πυρηνικά Ορός Πυρηνικό Σύνδρομο Sjogrens-Α εκχυλίσιμο πυρηνικό Σύνδρομο Sjogrens-Α εκχυλίσιμο πυρηνικό 60kD |
| es-ES | Spanish (Spain) | Ag extraible nuclear de 60 kD del Síndrome de Sjogrens Anticuerpos: |
| es-MX | Spanish (Mexico) | Síndrome de Sjogrens: |
| fr-CA | French (Canada) | Syndrome de Sjögren-a nucléaire soluble 60kD, Ac: |
| fr-FR | French (France) | SSA/Ro60 kD Ac: |
| fr-BE | French (Belgium) | Syndrome de Sjögren-a nucléaire soluble 60kD Ac: Synonyms: Anticorps |
| it-IT | Italian (Italy) | Sjorgen, sindrome-nucleare estraibile A 60kD Ab: Synonyms: anticorpo ENA Presenza o Soglia Punto nel tempo (episodio) Siero Sierologia (anticorpi e la maggior parte degli ant Sindrome di Sjorgen - nucleare estraibile A Sindrome di Sjorgen - nucleare estraibile A 60kD |
| nl-NL | Dutch (Netherlands) | syndroom van Sjögren-A extraheerbare nucleaire 60kD As: Synonyms: antistof; |
| pl-PL | Polish (Poland) | Zespół Sjogrena-rozpuszczalne jądrowe białko A 60kD Ab: Synonyms: Zespół Sjogrena-rozpuszczalne jądrowe białko A o masie 60 kDa |
| pt-BR | Portuguese (Brazil) | SS-A 60kD Ac: Synonyms: ; |
| ru-RU | Russian (Russian Federation) | Шегрена синдром-A экстрагируемый ядерный 60кД Ат: Synonyms: Антитело Порядковый Сыворотка Точка во времени; |
| tr-TR | Turkish (Turkey) | Sjögrens sendromu-A özütlenebilir nükleer 60kD Ab: Synonyms: Ak Çekirdek Mevcut |
| zh-CN | Chinese (China) | Sjogrens 综合征-a 可提取性核 60kD 抗体: Synonyms: A 型 Ab; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://